Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Survival in congestive heart failure: have we made a difference?
B. G. Firth
*
,
C. W. Yancy
*
Corresponding author for this work
Medicine, Cardiology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Survival in congestive heart failure: have we made a difference?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Congestive Heart Failure
100%
United States
50%
Traditional Therapy
50%
Disease Process
50%
Diuretics
50%
Digitalis
50%
Heart Failure
25%
Population Aging
25%
Surgical Treatment
25%
New Patients
25%
Mortality Rate
25%
Medical Therapy
25%
Disease Stage
25%
Transplant Experiment
25%
Effective Alternative
25%
Heart Transplantation
25%
Captopril
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Left Ventricular Remodeling
25%
Hydralazine
25%
Isosorbide Dinitrate
25%
Enalapril
25%
Severe Heart Failure
25%
Vasodilator Therapy
25%
Left Ventricular Dilatation
25%
Medicine and Dentistry
Congestive Heart Failure
100%
Disease Process
40%
Diuretics
40%
Enalapril
20%
ACE Inhibitor
20%
Patient with Congestive Heart Failure
20%
Mortality Rate
20%
Combination Therapy
20%
Heart Transplantation
20%
Isosorbide Dinitrate
20%
Captopril
20%
Hydralazine
20%
Nursing and Health Professions
Congestive Heart Failure
100%
Diseases
40%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Dilatation
20%
Patient with Congestive Heart Failure
20%
Combination Therapy
20%
Mortality Rate
20%
Heart Transplantation
20%
Captopril
20%
Hydralazine
20%
Enalapril
20%
Isosorbide Dinitrate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Diseases
33%
Diuretics
33%
Captopril
16%
Hydralazine
16%
Mortality Rate
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Enalapril
16%
Combination Therapy
16%
Isosorbide Dinitrate
16%